Nerve Pain School · Lesson 9
Preparing for a follow-up visit
Follow-up is where a gabapentin or nerve-pain plan is judged. Bring the original goal, a short symptom record, the actual bottles, and a decision you want made—continue, adjust, investigate, or stop under supervision.
Re-open the original contract
A follow-up that starts with “how are you?” without restating the goal often ends with an automatic refill. Remind the clinician what you both hoped would change: fewer seizures, more livable post-shingles pain, safer walking, better RLS nights, or a time-limited off-label trial.
If you never agreed on a review date, ask for one. Open-ended gabapentin without a purpose is how people accumulate sedating medicines for years.
Bring evidence, not a closing argument
A one-page note with dates of falls, near-sleep driving, swelling, mood change, or genuine functional gains is enough. Bring the bottles so the product on the desk matches the product in the chart. Mention kidney labs if they were drawn elsewhere.
If cost or pharmacy delays caused missed doses, say so. Missed doses can look like treatment failure and can also be a withdrawal-risk issue if the drug was stopped suddenly.
Decide what “stop” and “change” would require
If the medicine is not helping, the question is not only “whether” to stop but “how.” Labeling advises gradual withdrawal directed by the prescriber, especially when seizures are possible. If adverse effects dominate, ask whether a product switch (for example, a hospital generic versus Gralise) might explain the mismatch before anyone assumes the whole class failed.
Do not leave the visit with two clinicians independently planning opposite changes. Ask who writes the next prescription.
Use tools without outsourcing the visit
The Appointment Prep Kit on this site can store questions in the browser for printing. Label Decoder can help you interpret pharmacy phrases before you arrive. Neither tool is a clinic portal, and neither should be used to calculate a new dose.
Takeaways
- Restate the treatment goal before discussing refills.
- Bring bottles, a short timeline, and any kidney or mood information.
- Stopping still needs a clinician-directed plan; do not convert a disappointing visit into an abrupt halt.
Ask a clinician
- Are we continuing, changing, investigating another cause, or planning a supervised stop?
- When is the next hard review date?
- What should I do if I run out before that date?
Sources
- DailyMed: NEURONTIN (gabapentin) capsules, tablets, and oral solution — U.S. National Library of Medicine
- MedlinePlus: Gabapentin — MedlinePlus / National Library of Medicine